What is the purpose of a drug master file?
INTRODUCTION. A Drug Master File (DMF) is a submission to the Food and Drug Administration (FDA) that may be used to provide confidential detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of one or more human drugs.
What is FDA master file?
For CBER’s purposes, master files (MFs) are voluntary submissions of information to the FDA that may be used to provide confidential, detailed information to the FDA about the facilities, processes, or articles used in the manufacture, processing, packaging, or storing of one or more regulated products.
How do I know if my DMF is approved?
Search for DMF (Drug Master File) You can search for API DMF listing for any active ingredient to find listing status at FDA. Type II DMF of active ingredient is required to be submitted to FDA in order to submit ANDA. You can predict the potential future competitiveness by reviewing DMF listing of active ingredient.
What is a Type V master file?
Type V Drug Master Files for Center for Drug Evaluation and Research-Led Combination Products Using Device Constituent Parts With Electronics or Software; Draft Guidance for Industry; Availability.
Why is DMF needed?
The Main Objective of the DMF is to support regulatory requirements and to prove the quality, safety and efficacy of the medicinal product for obtaining an Investigational New Drug Application (IND), a New Drug Application (NDA),As an Abbreviated New Drug Application (ANDA), another DMF, or an Export Application.
What are master files?
A collection of records pertaining to one of the main subjects of an information system, such as customers, employees, products and vendors. Master files contain descriptive data, such as name and address, as well as summary information, such as amount due and year-to-date sales.
What is a master file?
What is included in a drug master file?
Drug master files (DMFs) are submissions to FDA used to provide confidential, detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of human drug products. They: Allow parties to reference material without disclosing DMF contents to those parties.
What is Drug Master File PDF?
A drug master file (DMF) is a confidential, detailed document submitted by Active Pharmaceutical Ingredient (API) manufacturers to the U.S. Food and Drug Administration (FDA). A drug master file is filed when two or more firms work in partnership on developing or manufacturing a drug product.
What are the types of drug master file?
Types of Drug Master Files (DMFs)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation; or Drug Product.
- Type III Packaging Material.
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation.
- Type V FDA-Accepted Reference Information.
What is site master file?
A Site Master File (SMF) is a document prepared by a manufacturer that provides specific, factual information about the production and control of manufacturing operations at a named site, as well as any closely integrated operations nearby buildings. SMFs are internationally harmonised documents.
What are the examples of master file?
Master files are files of a fairly permanent nature, e.g., customer ledger, purchase ledger, inventory pay roll etc. They include some information which is continuously updated by recent transactions.
What does FDA mean by drug master files?
This guidance provides FDA’s current thinking on drug master files (DMFs), which are submissions to FDA that may be used to provide confidential, detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of human drug products.
How to submit a DMF to the FDA?
If any holder wishes to submit information and supporting data in a DMF that is not covered by Types I through IV, a holder must first submit a letter of intent to the Drug Master File Staff (for address, see D.5.a. of this section). FDA will then contact the holder to discuss the proposed submission.
How big should a drug master file be?
The original and duplicate copies must be collated, fully assembled, and individually jacketed. Each volume of a DMF should, in general, be no more than 2 inches thick. For multivolume submissions, number each volume. For example, for a 3 volume submission, the volumes would be numbered 1 of 3, 2 of 3, and 3 of 3.
Can a MAF be submitted to any FDA Center?
This guideline only applies to the master files (MAFs) submitted to the Center for Devices and Radiological Health (CDRH). Master files in support of other products regulated by FDA, even though they may contain information previously submitted in an MAF, are to be submitted to the appropriate FDA center (s).